Efficacy, safety of switching to latanoprostene bunod 0.024% in patients with OAG and OHT Ophthalmology Times, 11 Apr 2024 The switch may produce an additional 25% IOP reduction in mild to moderate forms of disease (Image Credit: AdobeStock/Davizro…